Dr. Russell R Blakeley, M.D. Internal Medicine - Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 606 N Third Ave, Suite 203, Sandpoint, ID 83864 Phone: 208-263-8505 Fax: 208-263-2908 |
Charles Crane, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 102 Euclid Avenue, Suite 202, Sandpoint, ID 83864 Phone: 208-263-6876 Fax: 208-263-2033 |
Dr. Gregory D Pennock, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 423 N Third Ave Ste 335, Sandpoint, ID 83864 Phone: 208-265-7070 Fax: 208-265-7071 |
Scott Burgstahler, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 207 Church St, Sandpoint, ID 83864 Phone: 208-263-6876 Fax: 208-263-2033 |
Lawrence Derbes Jr., MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 423 N Third Ave Ste 355, Sandpoint, ID 83864 Phone: 208-265-7070 Fax: 208-265-7071 |
Dr. Ronald D Jenkins, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 606 N 3rd Ave, Suite 203, Sandpoint, ID 83864 Phone: 208-263-2505 Fax: 208-263-2908 |
News Archive
Boston researchers have developed a new way to generate groups of intestinal cells that can be used, among others, to make disease models in the lab to test treatments for diseases affecting the gastrointestinal system.
The U.S. Patent and Trademark Office (USPTO) has issued a notice of allowance related to Cenestra Health's high-purity omega-3 fatty acid formulations and their methods of use.
IMS Health, the world's leading provider of market intelligence to the pharmaceutical and healthcare industries, today announced the launch of IMS Aggregate Spend Compliance Services, a comprehensive set of solutions to help pharmaceutical and medical device companies comply with the growing number of federal and state transparency and marketing disclosure laws in the U.S., known as "aggregate spend" reporting regulations.
Researchers at Johns Hopkins may have discovered an unintended benefit in the drugs millions of Americans take to lower their cholesterol: The medications, all statins, seem to lower the risk of a potentially lethal blood infection known as sepsis in patients on kidney dialysis.
Malaysian scientists are joining forces with Harvard University experts to help revolutionize the treatment of lung diseases - the delivery of nanomedicine deep into places otherwise impossible to reach.
› Verified 1 days ago